Related references
Note: Only part of the references are listed.New Promise and Opportunities for Allosteric Kinase Inhibitors
Xiaoyun Lu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2
Markus Pietsch et al.
BIOORGANIC CHEMISTRY (2020)
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2020)
Inhibitors and fluorescent probes for protein kinase PKAc beta and its S54L mutant, identified in a patient with cortisol producing adenoma
Olivier Etebe Nonga et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2020)
Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for ...
Simon J. Cook et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Amer M. Zeidan et al.
CLINICAL CANCER RESEARCH (2020)
Design of a dual ERK5 kinase activation and autophosphorylation inhibitor to block cancer stem cell activity
Samanth R. Kedika et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
Liling Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Impact of ERK5 on the Hallmarks of Cancer
Barbara Stecca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting ERK1/2 protein-serine/threonine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Rational drug-design approach supported with thermodynamic studies - a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2
Maria Winiewska-Szajewska et al.
SCIENTIFIC REPORTS (2019)
Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity
Thayer K. Darling et al.
FRONTIERS IN IMMUNOLOGY (2019)
Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)
Richard A. Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5
Duy Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
MEK5/ERK5 activation regulates colon cancer stem-like cell properties
Diane M. Pereira et al.
CELL DEATH DISCOVERY (2019)
Conceptional Design of Self-Assembling Bisubstrate-like Inhibitors of Protein Kinase A Resulting in a Boronic Acid Glutamate Linkage
Janis Mueller et al.
ACS OMEGA (2019)
Progress with covalent small-molecule kinase inhibitors
Zheng Zhao et al.
DRUG DISCOVERY TODAY (2018)
Kinase inhibitors in clinical practice: An expanding world
Ruchi Pandey et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis
Simona Pavan et al.
ONCOGENE (2018)
ERK5 is activated by oncogenic BRAF and promotes melanoma growth
Ignazia Tusa et al.
ONCOGENE (2018)
Constrained peptides' time to shine?
Chris Morrison
NATURE REVIEWS DRUG DISCOVERY (2018)
Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase
Samanth Reddy Kedika et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
Ignazia Tusa et al.
STEM CELL REPORTS (2018)
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview
Peter M. Fischer
MEDICINAL RESEARCH REVIEWS (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
Bernhard C. Lechtenberg et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Boettger et al.
PLOS ONE (2017)
Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8carboxylic acid scaffold as picomolar inhibitors of CK2
Juergen Vahter et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Slowly on, Slowly off: Bisubstrate-Analogue Conjugates of 5-Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin
Katrin Kestav et al.
CHEMBIOCHEM (2017)
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
Giorgio Cozza
PHARMACEUTICALS (2017)
Peptide-drug conjugates as effective prodrug strategies for targeted delivery
Yin Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity
Carrie M. Gower et al.
ACS CHEMICAL BIOLOGY (2016)
Development of Bifunctional Inhibitors of Polo-Like Kinase1 with Low-Nanomolar Activities Against the Polo-Box Domain
Andrej Scharow et al.
CHEMBIOCHEM (2016)
Bifunctional Ligands for Inhibition of Tight-Binding Protein Protein Interactions
Taavi Ivan et al.
BIOCONJUGATE CHEMISTRY (2016)
Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain
Taylor K. Johnson et al.
BIOCONJUGATE CHEMISTRY (2016)
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa S. Rodrik-Outmezguine et al.
NATURE (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
ERK5 kinase activity is dispensable for cellular immune response and proliferation
Emme C. K. Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors
Darja Lavogina et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2016)
Exquisitely Specific Bisubstrate Inhibitors of c-Src Kinase
Kristoffer R. Brandvold et al.
ACS CHEMICAL BIOLOGY (2015)
Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity
Giorgio Cozza et al.
BIOCHEMICAL JOURNAL (2015)
Acetoxymethyl Ester of Tetrabromobenzimidazole-Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells
Kaido Viht et al.
BIOCONJUGATE CHEMISTRY (2015)
Bisubstrate Inhibitor Approach for Targeting Mitotic Kinase Haspin
Katrin Kestav et al.
BIOCONJUGATE CHEMISTRY (2015)
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer
S. M. Reddy et al.
INVESTIGATIONAL NEW DRUGS (2015)
Allosteric small-molecule kinase inhibitors
Peng Wu et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases
Ruben K. Dagda et al.
REVIEWS IN THE NEUROSCIENCES (2015)
Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration
Frank E. Kwarcinski et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L
Chengli Song et al.
ONCOTARGET (2015)
Single Turnover Autophosphorylation Cycle of the PKA RIIβ Holoenzyme
Ping Zhang et al.
PLOS BIOLOGY (2015)
Chronic Pain: New Insights in Molecular and Cellular Mechanisms
Livio Luongo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Inhibition of CREB Phosphorylation by Conjugates of Adenosine Analogues and Arginine-Rich Peptides, Inhibitors of PKA Catalytic Subunit
Marie Kriisa et al.
CHEMBIOCHEM (2015)
MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
Emily K. Slotkin et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Benzoselenadiazole-based responsive long-lifetime photoluminescent probes for protein kinases
Ramesh Ekambaram et al.
CHEMICAL COMMUNICATIONS (2014)
Bivalent inhibitors of protein kinases
Carrie M. Gower et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Translational evidence on the role of Src kinase and activated Src kinase in invasive breast cancer
Beatrix Elsberger
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer
Adriana Zamecnikova
EXPERT OPINION ON DRUG DISCOVERY (2014)
Modulation of the Chromatin Phosphoproteome by the Haspin Protein Kinase
Alessio Maiolica et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Advances in kinase targeting: current clinical use and clinical trials
Mathias Rask-Andersen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Activation pathway of Src kinase reveals intermediate states as targets for drug design
Diwakar Shukla et al.
NATURE COMMUNICATIONS (2014)
Cell-Penetrating Bisubstrate-Based Protein Kinase C Inhibitors
Loek T. M. van Wandelen et al.
ACS CHEMICAL BIOLOGY (2013)
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
Bryan W. Day et al.
CANCER CELL (2013)
Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
Meihui Chen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) Module
Gabor Glatz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Autoinhibition and Polo-Dependent Multisite Phosphorylation Restrict Activity of the Histone H3 Kinase Haspin to Mitosis
Cristina Ghenoiu et al.
MOLECULAR CELL (2013)
Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK
Peter D. Mace et al.
NATURE COMMUNICATIONS (2013)
Irreversible Inhibitors of c-Src Kinase That Target a Nonconserved Cysteine
Frank E. Kwarcinski et al.
ACS CHEMICAL BIOLOGY (2012)
Development of a Highly Selective c-Src Kinase Inhibitor
Kristoffer R. Brandvold et al.
ACS CHEMICAL BIOLOGY (2012)
Time-gated luminescence assay using nonmetal probes for determination of protein kinase activity-based disease markers
Marje Kasari et al.
ANALYTICAL BIOCHEMISTRY (2012)
Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro
Carolin C. Schneider et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors
Gregory D. Cuny et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
Vandana Lamba et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer
Guanglei Zhuang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies
Barbara Valsasina et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
Assembly of allosteric macromolecular switches: lessons from PKA
Susan S. Taylor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
D. Huertas et al.
ONCOGENE (2012)
A subnanomolar fluorescent probe for protein kinase CK2 interaction studies
Erki Enkvist et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
Protein-Induced Long Lifetime Luminescence of Nonmetal Probes
Erki Enkvist et al.
ACS CHEMICAL BIOLOGY (2011)
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
Arvin C. Dar et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL BREAST CANCER (2011)
Design and Characterization of a Potent and Selective Dual ATP- and Substrate-Competitive Subnanomolar Bidentate c-Jun N-Terminal Kinase (JNK) Inhibitor
John L. Stebbins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
Fabrice Pierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
KRAS and BRAF: drug targets and predictive biomarkers
Efsevia Vakiani et al.
JOURNAL OF PATHOLOGY (2011)
Plk1-Targeted Small Molecule Inhibitors: Molecular Basis for Their Potency and Specificity
Ravichandran N. Murugan et al.
MOLECULES AND CELLS (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
Marie Cargnello et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
Current Status of Src Inhibitors in Solid Tumor Malignancies
Lauren N. Puls et al.
ONCOLOGIST (2011)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1
Xianming Deng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein
Qingkai Yang et al.
CANCER CELL (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
Cellular regulators of protein kinase CK2
Mathias Montenarh
CELL AND TISSUE RESEARCH (2010)
Bisubstrate Inhibitors of Protein Kinases: from Principle to Practical Applications
Darja Lavogina et al.
CHEMMEDCHEM (2010)
Haspin: a newly discovered regulator of mitotic chromosome behavior
Jonathan M. G. Higgins
CHROMOSOMA (2010)
Targeting Polo-like Kinase in Cancer Therapy
Yan Degenhardt et al.
CLINICAL CANCER RESEARCH (2010)
The Src Family of Protein Tyrosine Kinases: A New and Promising Target for Colorectal Cancer Therapy
Christopher Lieu et al.
CLINICAL COLORECTAL CANCER (2010)
Diversity of Bisubstrate Binding Modes of Adenosine Analogue-Oligoarginine Conjugates in Protein Kinase A and Implications for Protein Substrate Interactions
Alexander Pflug et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang et al.
NATURE (2010)
High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK
Angela Vaasa et al.
ANALYTICAL BIOCHEMISTRY (2009)
Peripheral Delivery of a ROCK Inhibitor Improves Learning and Working Memory
Matthew J. Huentelman et al.
BEHAVIORAL NEUROSCIENCE (2009)
Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): Optimization and selectivity profiling
Carolyn D. Shomin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Targeting the RAF-MEK-ERK pathway in cancer therapy
Clara Montagut et al.
CANCER LETTERS (2009)
Protein kinase CK2: An ugly duckling in the kinome pond
L. A. Pinna et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
William E. Tidyman et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation
Jean-Francois Tanti et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Structural Analysis of ARC-Type Inhibitor (ARC-1034) Binding to Protein Kinase A Catalytic Subunit and Rational Design of Bisubstrate Analogue Inhibitors of Basophilic Protein Kinases
Darja Lavogina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Targeting protein kinases in central nervous system disorders
Laura K. Chico et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization
Fabrizio Villa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure and functional characterization of the atypical human kinase haspin
Jeyanthy Eswaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Protein kinase CK2 in human diseases
Barbara Guerra et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton
Helin Raagel et al.
FEBS JOURNAL (2008)
Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs
Douglas L. Sheridan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tuning a Three-Component Reaction For Trapping Kinase Substrate Complexes
Alexander V. Statsuk et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Structural and Thermodynamic Approach to Peptide Immunogenicity
Carlos J. Camacho et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Tethering small molecules to a phage display library: Discovery of a selective bivalent inhibitor of protein kinase A
Scott C. Meyer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules
Roberto Battistutta et al.
CHEMBIOCHEM (2007)
Carbocyclic 3′-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases
Erki Enkvist et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases
Erki Enkvist et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor
Laurent F. Hennequin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage - Results of a randomized trial of fasudil hydrochloride versus nimodipine
Jizong Zhao et al.
NEUROLOGIA MEDICO-CHIRURGICA (2006)
Dynamics of signaling by PKA
SS Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex
M Ohori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Increasing the kinase specificity of K252a by protein surface recognition
TL Schneider et al.
ORGANIC LETTERS (2005)
The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment
J Dai et al.
GENES & DEVELOPMENT (2005)
PKA: a portrait of protein kinase dynamics
SS Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
c-Src and cooperating partners in human cancer
R Ishizawar et al.
CANCER CELL (2004)
Toward a pharmacophore for kinase frequent hitters
AM Aronov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A
AC Hines et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Polo-like kinases and the orchestration of cell division
FA Barr et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Functional roles of the Rho/Rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin - Relevance to subarachnoid hemorrhage and vasospasm
G Wickman et al.
CIRCULATION RESEARCH (2003)
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion
PB Mehta et al.
ONCOGENE (2003)
One-thousand-and-one substrates of protein kinase CK2?
F Meggio et al.
FASEB JOURNAL (2003)
Structure, function and evolution of haspin and haspin-related proteins, a distinctive group of eukaryotic protein kinases
JMG Higgins
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Haspin-like proteins: A new family of evolutionarily conserved putative eukaryotic protein kinases
JMG Higgins
PROTEIN SCIENCE (2001)
Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation
RR Adams et al.
JOURNAL OF CELL BIOLOGY (2001)
Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue
D Reissig et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
A novel casein kinase 2 α-subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7
XY Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Selected glimpses into the activation and function of Src kinase
JD Bjorge et al.
ONCOGENE (2000)
Role of Src expression and activation in human cancer
RB Irby et al.
ONCOGENE (2000)
The protein tyrosine kinase family of the human genome
DR Robinson et al.
ONCOGENE (2000)
Share Paper
